Mersana Therapeutics, Inc.
MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

Last updated:

Abstract:

This invention provides fully human monoclonal antibodies that recognize HER2. The invention further provides methods of using such monoclonal antibodies in a variety of therapeutic, diagnostic, and prophylactic indications.

Status:
Application
Type:

Utility

Filling date:

2 Oct 2019

Issue date:

30 Jan 2020